Coffee is not classified as a carcinogen. In 2016, the International Agency for Research on Cancer (IARC) formally downgraded coffee from “possibly carcinogenic” to “not classifiable,” after reviewing more than 1,000 studies and finding no consistent evidence that coffee drinking increases cancer risk. The research has actually tilted the other way: regular coffee consumption is linked to lower rates of several cancers, with the strongest evidence for liver and colorectal cancers. But the story has layers worth understanding, from the chemical compounds formed during roasting to the way your personal genetics might change what coffee does in your body.
How Coffee Lost Its “Possibly Carcinogenic” Label
Back in 1991, IARC placed coffee in Group 2B, meaning it was “possibly carcinogenic to humans.” That classification was based largely on early studies of bladder cancer that, as we now understand, were muddied by confounding factors like smoking. Coffee drinkers in those decades were far more likely to also be smokers, and the studies did not always account for that overlap well enough.
In 2016, IARC convened a working group that re-evaluated decades of accumulated evidence. The group found no consistent link between coffee drinking and cancers of the pancreas, breast, or prostate. It also found that coffee was associated with reduced risk of liver and endometrial cancers. The result was a move from Group 2B to Group 3, meaning the evidence was inadequate to call coffee a human carcinogen in either direction. Importantly, the same working group did classify drinking “very hot beverages” (above about 65°C) as “probably carcinogenic,” a distinction that matters when we talk about how coffee is consumed rather than what coffee is.1The Lancet Oncology. Carcinogenicity of drinking coffee, mate, and very hot beverages
The Acrylamide Paradox
Roasting coffee beans produces acrylamide, a chemical that has been classified as a “probable carcinogen” based on high-dose animal studies. Acrylamide forms through the Maillard reaction, the same browning chemistry that gives roasted coffee its flavor and color.2PubMed Central. Production and Inhibition of Acrylamide during Coffee Processing: A Literature Review This is what drove California’s infamous legal battle that nearly required cancer warning labels on coffee cups.
The problem with extrapolating from animal studies, though, is dose. The amounts of acrylamide given to lab rodents dwarf what any human would get from drinking coffee. When researchers have looked at actual human populations, dietary acrylamide exposure has shown no clear link to cancer incidence. A large Japanese cohort study, for example, found no association between dietary acrylamide and endometrial or ovarian cancer.3PubMed Central. Dietary acrylamide intake and the risk of endometrial or ovarian cancers in Japanese women The broader picture is even more puzzling: coffee is a major contributor to dietary acrylamide, yet coffee drinkers tend to have lower overall cancer rates. Researchers have called this the “coffee-acrylamide apparent paradox” and argue it illustrates why you cannot evaluate a single compound in isolation from the hundreds of other bioactive molecules in a complex food.4PubMed Central. The Coffee-Acrylamide Apparent Paradox: An Example of Why the Health Impact of a Specific Compound in a Complex Mixture Should Not Be Evaluated in Isolation
Temperature Matters More Than the Drink Itself
When IARC cleared coffee in 2016, it simultaneously flagged very hot beverages as a probable cause of esophageal cancer. The concern is thermal injury: repeatedly scalding the lining of the esophagus can trigger chronic inflammation and cell damage that, over time, may promote cancer. This risk applies to any liquid consumed at very high temperatures and has been studied extensively in cultures where tea or mate is traditionally served near boiling.
For coffee specifically, a systematic review of case-control studies found mixed results: some showed increased esophageal cancer risk with very hot coffee, while others showed no significant association.5PubMed Central. High-temperature beverages and Foods and Esophageal Cancer Risk — A Systematic Review A more recent meta-analysis attempted to pool the data on high-temperature versus lower-temperature coffee and found a point estimate suggesting about a 50% increase in risk, but the result was not statistically significant, was driven heavily by a single outlier study, and showed substantial inconsistency across studies. When that outlier was removed, the estimate dropped to essentially no effect.6PubMed Central. The association between coffee consumption and esophageal cancer risk: a systematic review and meta-analysis of current observational evidence The practical takeaway: if you let your coffee cool to a comfortable drinking temperature before sipping, this concern largely disappears.
Why Coffee Might Protect Against Cancer
Coffee contains well over a thousand bioactive compounds, and several of them have demonstrated anti-cancer properties in laboratory and animal studies. The most studied are chlorogenic acids, the dominant phenolic compounds in coffee. These act as antioxidants and have shown anti-inflammatory and anti-carcinogenic effects across a range of experimental models.7PubMed Central. The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological Diseases Beyond their direct antioxidant activity, chlorogenic acids have been linked to anti-diabetic and anti-obesity effects, which themselves influence cancer risk since obesity and insulin resistance are established risk factors for several cancer types.8PubMed. The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature
Then there are cafestol and kahweol, two diterpene compounds unique to coffee. In cell and animal studies, these molecules have reduced the toxic effects of several known carcinogens through multiple pathways: they ramp up the body’s detoxification enzymes, boost antioxidant defenses, and suppress enzymes that activate carcinogens in the first place.9Food and Chemical Toxicology. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity Research in mouse cells has shown that coffee activates a protective signaling pathway mediated by a protein called Nrf2, which controls genes involved in cellular defense. Cafestol and kahweol appear to be key drivers of this activation.10Toxicology and Applied Pharmacology. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2
Worth noting: cafestol and kahweol are present in higher amounts in unfiltered coffee (like French press or Turkish coffee) because paper filters trap much of the oily fraction where these compounds live. The flip side is that cafestol also raises LDL cholesterol, so unfiltered coffee involves a cardiovascular trade-off that filtered coffee mostly avoids.
Liver Cancer Has the Strongest Evidence
If there is one cancer site where the data on coffee are most convincing, it is the liver. A meta-analysis published in Gastroenterology found that every additional two cups of coffee per day was associated with a roughly 43% lower risk of liver cancer.11PubMed. Coffee consumption and risk of liver cancer: a meta-analysis An updated meta-analysis of 16 studies confirmed the pattern, finding about a 40% lower risk overall among coffee drinkers compared to non-drinkers, with a dose-response relationship: each additional daily cup was associated with about a 20% lower risk.12Clinical Gastroenterology and Hepatology. Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis This inverse association held regardless of sex, alcohol intake, or pre-existing hepatitis or liver disease.
The relationship extends beyond cancer to liver health generally. More than two cups per day has been associated with lower rates of fibrosis, cirrhosis, and liver-related mortality in people who already have liver disease.13PubMed Central. Coffee and Liver Disease Coffee’s combination of anti-inflammatory compounds, antioxidant activity, and effects on fat metabolism in the liver likely all contribute, though the exact mechanisms are still being worked out.
Colorectal Cancer and Endometrial Cancer
After liver cancer, colorectal and endometrial cancers have the next most consistent bodies of evidence. A large case-control study found that any coffee consumption was associated with about a 26% reduction in colorectal cancer odds, with a clear dose-response: people drinking more than two and a half servings per day had roughly half the odds compared with light drinkers.14PubMed Central. Coffee Consumption and the Risk of Colorectal Cancer And for people who have already been diagnosed, coffee still seems to help. A study of stage III colon cancer patients found that those drinking four or more cups per day had about a 42% lower risk of cancer recurrence or death compared to non-drinkers, with caffeinated coffee showing a stronger association than decaffeinated.15PubMed Central. Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) A separate study echoed this, finding that more than four cups daily was linked to about a 32% lower risk of colorectal cancer recurrence.16PubMed. Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all-cause mortality
For endometrial cancer, a dose-response meta-analysis of prospective cohort studies found that an increase of four cups per day was associated with about a 20% reduction in risk overall, with a stronger effect (about 24% reduction) in postmenopausal women.17PubMed Central. Coffee Decreases the Risk of Endometrial Cancer: A Dose–Response Meta-Analysis of Prospective Cohort Studies One cohort study of Swedish women found that the benefit appeared to be concentrated among overweight and obese women, with normal-weight women showing no significant association.18PubMed Central. Coffee drinking and risk of endometrial cancer–a population-based cohort study This makes biological sense: excess body weight promotes endometrial cancer partly through elevated estrogen and insulin levels, and coffee’s effects on insulin sensitivity and inflammation could plausibly counteract that pathway.
Prostate Cancer and Where the Data Get Thinner
For prostate cancer, the evidence is more modest and depends on what type of prostate cancer you are talking about. A dose-response meta-analysis found that three additional cups per day was associated with about an 11% lower risk of fatal prostate cancer, but the associations for low-grade, localized, and advanced prostate cancer were weaker and mostly not statistically significant.19Annals of Oncology. Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer—a dose–response meta-analysis The most striking finding came from the Health Professionals Follow-up Study, where men drinking six or more cups per day had a 60% lower risk of lethal prostate cancer compared with non-drinkers, an association the researchers attributed to non-caffeine components.20JNCI: Journal of the National Cancer Institute. Coffee Consumption and Prostate Cancer Risk and Progression in the Health Professionals Follow-up Study That is a big effect size from a single cohort, so it warrants some caution until replicated more broadly.
A systematic review and meta-analysis that combined results from multiple studies found a pooled risk reduction of about 7% for localized prostate cancer among higher coffee consumers, with trends toward lower risk for advanced and fatal disease that did not quite reach statistical significance.21PubMed Central. Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis In other words, there may be something real here, but the effect appears smaller than what has been observed for liver, colorectal, or endometrial cancers.
Caffeinated Versus Decaf
If you drink decaf, you might wonder whether you are missing out on the protective effects. A meta-analysis comparing caffeinated and decaffeinated coffee across several cancer types found that the answer depends on the cancer. For liver cancer, caffeinated coffee was associated with about a 46% risk reduction, while decaffeinated showed only a 16% reduction that was not statistically significant. For endometrial cancer, both caffeinated and decaffeinated coffee were linked to lower risk, but the caffeinated association was stronger. For skin cancer, caffeinated coffee showed a significant 18% reduction, while decaf showed essentially no effect.22medRxiv. Caffeinated or decaffeinated coffee consumption and risk of cancer incidence: meta-analyses of prospective cohort studies
Interestingly, the pattern flipped for colorectal cancer: decaffeinated coffee showed a trend toward lower risk, while caffeinated coffee showed no association at all. A large prospective study found similar patterns, with decaf coffee showing a significant dose-response trend for both colon and rectal cancers.23PubMed Central. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study This suggests that different compounds in coffee protect different organs, and caffeine is not always the key player. Chlorogenic acids, diterpenes, and other phenolics are present in both caffeinated and decaffeinated coffee, which may explain why decaf still shows benefits for some cancer sites.
Why Smoking Confused the Picture for Decades
One of the biggest reasons coffee was once suspected of causing cancer comes down to a classic epidemiological trap: confounding by smoking. For much of the 20th century, coffee drinkers were substantially more likely to be smokers. If you simply compared cancer rates between heavy coffee drinkers and non-drinkers without carefully accounting for tobacco use, coffee looked guilty by association.
This is especially apparent for lung cancer. A large study using the NIH-AARP Diet and Health cohort found a positive association between coffee drinking and lung cancer, but the link substantially weakened after adjusting for tobacco use. The researchers concluded that even with their adjustment, residual confounding by smoking likely explained the remaining association.24PubMed Central. Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study An earlier Norwegian cohort study of over 43,000 people found a similar pattern: coffee appeared linked to lung cancer even after adjusting for smoking, but the researchers acknowledged that residual confounding could not be ruled out.25PubMed. Coffee and cancer: a prospective study of 43,000 Norwegian men and women
A large analysis from the Cancer Prevention Study-II found evidence of residual confounding by smoking dose and duration among both current and former smokers, reinforcing that early associations between coffee and various cancers were artifacts of tobacco use rather than genuine effects of coffee itself.26Cancer Epidemiology, Biomarkers & Prevention. Associations of Coffee Drinking and Cancer Mortality in the Cancer Prevention Study-II When analyses are restricted to never-smokers, coffee’s associations with cancer risk either disappear (for lung cancer) or turn protective (for liver, colorectal, and endometrial cancers). This is the single most important methodological lesson in coffee-cancer research: always check whether the study adequately controlled for smoking.
Your Genes May Shift the Equation
Not everyone metabolizes coffee the same way, and there is growing evidence that your genetic makeup can influence whether coffee is more or less protective against certain cancers. The gene CYP1A2 encodes the primary liver enzyme responsible for metabolizing caffeine. A common variant of this gene makes the enzyme less active, meaning caffeine sticks around longer in the body.
In a study of women carrying BRCA1 mutations (who are at elevated risk for breast cancer), those with at least one copy of the slower CYP1A2 variant who drank coffee had a 64% lower risk of breast cancer compared to non-coffee drinkers with the same variant. Among women with the faster-metabolizing version of the gene, coffee showed no significant protective effect.27PubMed. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers This is a single study in a specific high-risk population, so it should not be over-interpreted, but it illustrates that coffee’s effects on cancer risk are not one-size-fits-all.
The same gene appears in ovarian cancer research as well. A study found that the association between caffeine intake and ovarian cancer risk differed by CYP1A2 genotype, and was also influenced by other dietary factors like cruciferous vegetable consumption that affect the same enzyme’s activity.28PubMed. Association of caffeine intake and CYP1A2 genotype with ovarian cancer The field of gene-diet interactions in cancer is still young, and most findings remain preliminary. But the CYP1A2 story is a reminder that blanket statements about coffee and cancer will always have individual exceptions.
Coffee and Overall Cancer Mortality
Zooming out from individual cancer types, several large meta-analyses have examined whether coffee affects cancer mortality overall. A meta-analysis examining potential modifiers found that around two cups per day was associated with the lowest risk of cancer death, about a 4% reduction, with higher intakes showing no further benefit.29PubMed. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers A separate meta-analysis looking at smokers and non-smokers found that among never-smokers, each additional daily cup was associated with a small but consistent reduction in cancer mortality.30PubMed. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis A Mediterranean cohort study found a more dramatic effect, with coffee drinkers consuming more than one cup per day showing roughly 59% lower cancer mortality compared to non-drinkers, though that kind of effect size from a single cohort should be viewed as an upper-bound estimate.31PubMed Central. Coffee Consumption and All-Cause, Cardiovascular, and Cancer Mortality in an Adult Mediterranean Population
Overall, the pattern across these meta-analyses is consistent: moderate coffee consumption is associated with slightly lower cancer mortality, with the biggest reductions at around two to four cups per day and no clear benefit from drinking more.
Contaminants Worth Knowing About
The cancer risk picture for coffee would be incomplete without mentioning ochratoxin A (OTA), a mycotoxin produced by molds that can contaminate coffee beans during storage or processing. OTA has been classified as a possible human carcinogen, and it does show up in coffee products. A worldwide systematic review of over 3,200 coffee samples found OTA in about 55% of them, though the vast majority at levels below the maximum limits set by European regulators.32PubMed. A worldwide systematic review of ochratoxin A in various coffee products – human exposure and health risk assessment The same review concluded that the estimated daily intake of OTA from coffee falls well below internationally accepted safety thresholds, and that OTA in coffee is not toxic to consumers at normal consumption levels.
A smaller study measuring OTA in different coffee types found higher concentrations in roasted coffee and lower in instant coffee, with some risk estimates for certain product types exceeding comfort levels for neoplastic effects.33Arab Journal of Chemistry. Concentration of ochratoxin A in coffee products and probabilistic health risk assessment The discrepancy between these two assessments comes down to which coffee products and populations were studied and how risk was modeled. The broader review, drawing on data from dozens of countries, is more reassuring. Regulatory limits exist specifically to keep OTA levels in commercial coffee below dangerous thresholds, and properly stored, commercially produced coffee generally stays within those bounds.
What About What You Put in Your Coffee
Most of the research on coffee and cancer examines black coffee or coffee with minimal additions. If your daily habit involves flavored syrups, large amounts of sugar, or heavily processed creamers, the metabolic effects shift. Excess sugar intake promotes obesity and insulin resistance, both of which are established cancer risk factors. The same applies to high-calorie blended coffee drinks that bear little resemblance to the brew studied in epidemiological research. No study has shown that a 500-calorie caramel frappuccino protects against cancer the way plain coffee appears to. The vehicle matters: coffee’s bioactive compounds are not nullified by additions, but the health profile of the total drink changes substantially when you add significant sugar or fat.
Similarly, the polyphenols in coffee interact with your gut microbiota in ways that may contribute to its protective effects. Gut bacteria play a role in metabolizing phenolic compounds and producing bioactive metabolites, and dietary polyphenols in turn can shape the composition of the gut microbial community. This reciprocal relationship is an active area of research and may partly explain why coffee seems to benefit the colon specifically. But the gut microbiome is influenced by the entire diet, so the context in which coffee is consumed likely matters for how its compounds are processed and whether they reach the tissues where they could be protective.